Eran Perry
Direktor/Vorstandsmitglied bei COMPUGEN LTD.
Profil
Mr. Eran Perry is a Co-Founder and Board Member at Upstream Bio, Inc., a Co-Managing Director at Maruho Israel Innovation Fund and a Co-Founder at ICD Pharma Ltd.
He is on the Board of Directors at Upstream Bio, Inc. and Compugen Ltd.
Mr. Perry was previously employed as a Board Member by Musli Thyropeutics Ltd., a Partner by I.H.C.V Israel Healthcare Ventures Ltd., an Associate by Mckinsey & Co. /Israel/, and a Business Analyst by Novartis AG /U.S.
Biologics Manufacturing Operation/.
He received his MBA from Columbia Business School.
Aktive Positionen von Eran Perry
Unternehmen | Position | Beginn |
---|---|---|
COMPUGEN LTD. | Direktor/Vorstandsmitglied | 01.07.2017 |
Maruho Israel Innovation Fund
Maruho Israel Innovation Fund Financial ConglomeratesFinance Maruho Israel Innovation Fund engages in investments in dermatology-related technologies, biotech, medical devices, digital health, and cosmetics. The company was founded by Junichi Hamada, Eran Perry, Doron Friedman, and Masanobu Ogawa in 2018 and is headquartered in Rehovot, Israel. | Vorstandsvorsitzender | 01.01.2018 |
ICD Pharma Ltd. | Gründer | 01.04.2017 |
Upstream Bio, Inc.
Upstream Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Upstream Bio, Inc. is a clinical-stage biopharmaceutical company based in Waltham, MA, USA. The American company's lead program, upb-101, is a monoclonal antibody that inhibits the TSLP receptor, a validated target that affects various immune cells involved in common and rare diseases. Upstream Bio is leveraging its diverse roots and substantial industry experience to develop therapies that ease the burden of inflammatory and allergic diseases on patients and their loved ones. The company was founded by Eran Perry and Earn Perry, and Samantha Truex has been the CEO since 2021. | Gründer | 01.04.2021 |
Novartis Oncology | Vertrieb & Marketing | - |
MyBiotics Pharma Ltd.
MyBiotics Pharma Ltd. BiotechnologyHealth Technology MyBiotics Pharma Ltd. operates as a micro biome pharmaceutical company that develops live bacteria based drugs. It develops MyCrobe and SuperDonor technologies for growing specific bacterial communities on pre-selected particles for stable and resistant raw material and for multi bacterial products. The company was founded in and is headquartered in Ness Ziona, Israel. | Direktor/Vorstandsmitglied | - |
Noon Aesthetics Ltd.
Noon Aesthetics Ltd. Household/Personal CareConsumer Non-Durables Noon Aesthetics Ltd. is an Israeli skincare company that focuses on science-based, clinically-proven solutions to enhance the beauty and health of skin. Noon Aesthetics is based in Tel Aviv, IL and was founded in 2012 by Eran Rosman and Masha Minkin. The private company is committed to research and innovation to ensure that their products deliver tangible results and improve the overall well-being of patients. The company's products include the Restart Serum, which helps to repair DNA damage caused by oxidative stress, UV rays, air pollution, pesticides, and aging. Eran Rosman has been the CEO since 2012. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Eran Perry
Unternehmen | Position | Ende |
---|---|---|
Musli Thyropeutics Ltd. | Direktor/Vorstandsmitglied | 01.08.2021 |
I.H.C.V Israel Healthcare Ventures Ltd.
I.H.C.V Israel Healthcare Ventures Ltd. Investment ManagersFinance Israel Healthcare Ventures Ltd. (Israel Healthcare Ventures) is a venture capital firm founded in 2000 by Hadar Ron. The firm is headquartered in Tel Aviv, Israel. | Private Equity Investor | 01.09.2016 |
░░░░░░░░ ░░░░░ ░░░ ░░░░░░░░ | ░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░ ░░ ░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░ ░░░░░░░░░░ | ░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von Eran Perry
Tel-Aviv University | Graduate Degree |
Columbia Business School | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
COMPUGEN LTD. | Health Technology |
Private Unternehmen | 10 |
---|---|
I.H.C.V Israel Healthcare Ventures Ltd.
I.H.C.V Israel Healthcare Ventures Ltd. Investment ManagersFinance Israel Healthcare Ventures Ltd. (Israel Healthcare Ventures) is a venture capital firm founded in 2000 by Hadar Ron. The firm is headquartered in Tel Aviv, Israel. | Finance |
Novartis AG /U.S. Biologics Manufacturing Operation/ | Health Technology |
MyBiotics Pharma Ltd.
MyBiotics Pharma Ltd. BiotechnologyHealth Technology MyBiotics Pharma Ltd. operates as a micro biome pharmaceutical company that develops live bacteria based drugs. It develops MyCrobe and SuperDonor technologies for growing specific bacterial communities on pre-selected particles for stable and resistant raw material and for multi bacterial products. The company was founded in and is headquartered in Ness Ziona, Israel. | Health Technology |
Musli Thyropeutics Ltd. | |
Maruho Israel Innovation Fund
Maruho Israel Innovation Fund Financial ConglomeratesFinance Maruho Israel Innovation Fund engages in investments in dermatology-related technologies, biotech, medical devices, digital health, and cosmetics. The company was founded by Junichi Hamada, Eran Perry, Doron Friedman, and Masanobu Ogawa in 2018 and is headquartered in Rehovot, Israel. | Finance |
ICD Pharma Ltd. | |
Novartis Oncology | |
Upstream Bio, Inc.
Upstream Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Upstream Bio, Inc. is a clinical-stage biopharmaceutical company based in Waltham, MA, USA. The American company's lead program, upb-101, is a monoclonal antibody that inhibits the TSLP receptor, a validated target that affects various immune cells involved in common and rare diseases. Upstream Bio is leveraging its diverse roots and substantial industry experience to develop therapies that ease the burden of inflammatory and allergic diseases on patients and their loved ones. The company was founded by Eran Perry and Earn Perry, and Samantha Truex has been the CEO since 2021. | Commercial Services |
Noon Aesthetics Ltd.
Noon Aesthetics Ltd. Household/Personal CareConsumer Non-Durables Noon Aesthetics Ltd. is an Israeli skincare company that focuses on science-based, clinically-proven solutions to enhance the beauty and health of skin. Noon Aesthetics is based in Tel Aviv, IL and was founded in 2012 by Eran Rosman and Masha Minkin. The private company is committed to research and innovation to ensure that their products deliver tangible results and improve the overall well-being of patients. The company's products include the Restart Serum, which helps to repair DNA damage caused by oxidative stress, UV rays, air pollution, pesticides, and aging. Eran Rosman has been the CEO since 2012. | Consumer Non-Durables |
Mckinsey & Co. /Israel/ |